NYSE:PAH - Platform Specialty Products Stock Price, News, & Analysis

Platform Specialty Products trades on the New York Stock Exchange (NYSE) under the ticker symbol "PAH."

Platform Specialty Products Corp (NYSE:PAH) released its earnings results on Thursday, August, 2nd. The specialty chemicals company reported $0.26 earnings per share for the quarter, topping analysts' consensus estimates of $0.24 by $0.02. The specialty chemicals company earned $1 billion during the quarter, compared to the consensus estimate of $997.27 million. Platform Specialty Products had a positive return on equity of 8.48% and a negative net margin of 14.14%. The firm's revenue for the quarter was up 6.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.20 earnings per share. View Platform Specialty Products' Earnings History.

Platform Specialty Products is scheduled to release their next quarterly earnings announcement on Tuesday, February 26th 2019. View Earnings Estimates for Platform Specialty Products.

Platform Specialty Products updated its FY 2019 earnings guidance on Monday, January, 28th. The company provided EPS guidance of $0.75-0.80 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.73. Platform Specialty Products also updated its FY 2018 guidance to EPS.

6 Wall Street analysts have issued 1 year price targets for Platform Specialty Products' stock. Their forecasts range from $12.00 to $15.00. On average, they anticipate Platform Specialty Products' stock price to reach $13.25 in the next year. This suggests a possible upside of 18.4% from the stock's current price. View Analyst Price Targets for Platform Specialty Products.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Platform Specialty Products in the last year. There are currently 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Platform Specialty Products.

News headlines about PAH stock have trended somewhat positive on Saturday, according to InfoTrie Sentiment Analysis. The research group identifies positive and negative press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Platform Specialty Products earned a coverage optimism score of 1.7 on InfoTrie's scale. They also assigned headlines about the specialty chemicals company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the company's share price in the near future.

Some companies that are related to Platform Specialty Products include Versum Materials (VSM), Platform Specialty Products (ESI), Cabot (CBT), WD-40 (WDFC), Orion Engineered Carbons (OEC), Advanced Emissions Solutions (ADES), Flotek Industries (FTK), Pure Bioscience (PURE), HighCom Global Security (HCGS), GlyEco (GLYE), Artemis Therapeutics (ATMS) and Ener-Core (ENCR).

Based on aggregate information from My MarketBeat watchlists, some companies that other Platform Specialty Products investors own include Micron Technology (MU), Alibaba Group (BABA), Two Harbors Investment (TWO), Uniti Group (UNIT), Fitbit (FIT), Energy Transfer LP Unit (ET), Freeport-McMoRan (FCX), Intel (INTC), General Electric (GE) and Kratos Defense & Security Solutions (KTOS).

Platform Specialty Products' stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (5.74%), Dimensional Fund Advisors LP (5.50%), Gates Capital Management Inc. (2.33%), Vaughan Nelson Investment Management L.P. (1.41%), Victory Capital Management Inc. (1.26%) and Locust Wood Capital Advisers LLC (0.76%). Company insiders that own Platform Specialty Products stock include Benjamin Gliklich, Diego Lopez Casanello, Ian G H Ashken, John David Tolbert, John Edward Capps, Martin E Franklin, Pershing Square Capital Manage, Rakesh Sachdev and Scot Benson. View Institutional Ownership Trends for Platform Specialty Products.

PAH stock was sold by a variety of institutional investors in the last quarter, including Wedge Capital Management L L P NC, First Manhattan Co., First Trust Advisors LP, Raymond James & Associates, Victory Capital Management Inc., Van ECK Associates Corp, ETF Managers Group LLC and Ancora Advisors LLC. Company insiders that have sold Platform Specialty Products company stock in the last year include Martin E Franklin and Pershing Square Capital Manage. View Insider Buying and Selling for Platform Specialty Products.

PAH stock was purchased by a variety of institutional investors in the last quarter, including Consulta Ltd, Locust Wood Capital Advisers LLC, Vaughan Nelson Investment Management L.P., Gates Capital Management Inc., Royce & Associates LP, Hsbc Holdings PLC, BlackRock Inc. and Dimensional Fund Advisors LP. Company insiders that have bought Platform Specialty Products stock in the last two years include Benjamin Gliklich, Diego Lopez Casanello, Ian G H Ashken, John David Tolbert, John Edward Capps, Martin E Franklin, Pershing Square Capital Manage, Rakesh Sachdev and Scot Benson. View Insider Buying and Selling for Platform Specialty Products.

Shares of PAH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of PAH stock can currently be purchased for approximately $11.19.

Platform Specialty Products has a market capitalization of $3.23 billion and generates $3.78 billion in revenue each year. The specialty chemicals company earns $-296,200,000.00 in net income (profit) each year or $0.76 on an earnings per share basis. Platform Specialty Products employs 7,850 workers across the globe.

The official website for Platform Specialty Products is http://www.platformspecialtyproducts.com.

Platform Specialty Products' mailing address is 1450 CENTREPARK BLVD SUITE 210, WEST PALM BEACH FL, 33401. The specialty chemicals company can be reached via phone at (561) 207-9600.